-
CLINICIAN TESTING OF A PREFERENCE-BASED MEASURE TO TEST SENSITIVITY AND RELEVANCE FOR UTILITIES ESTIMATION IN EARLY HD
Mar 18, 2026, 21:38 PM -
REVIEW OF CELL THERAPY ACCESS LANDSCAPE
Mar 18, 2026, 21:38 PM -
FRAMEWORK FOR RWD TRANSFORMATIONS FROM NATIVE DATA MODELS TO CDISC DATA STANDARDS
Mar 18, 2026, 21:38 PM -
THE ROLE OF INNOVATIVE CONTRACTS IN ADDRESSING UNMET MEDICAL NEEDS FOR HIGH-BUDGET-IMPACT THERAPIES: EVIDENCE FROM THERAPEUTIC ANALOGUES AND IMPLICATIONS FOR OBESITY
Mar 18, 2026, 21:38 PM -
DISEASE BURDEN OF DIABETIC KIDNEY DISEASE IN CHINA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
ALIGNMENT OF HEALTH PLAN REAUTHORIZATION CRITERIA WITH CLINICAL TRIAL ENDPOINTS FOR NEUROMUSCULAR DISEASE THERAPIES
Mar 18, 2026, 21:38 PM -
RESHAPING ALLERGY ASSESSMENT PATHWAYS IN THE UNITED KINGDOM TO IMPROVE ACCESS, CAPACITY, AND VALUE: A DISCRETE EVENT SIMULATION
Mar 18, 2026, 21:38 PM -
AN AUTOMATED NETWORK META-ANALYSIS FRAMEWORK INTEGRATING INTELLIGENT ALGORITHMS AND LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND TOTAL COST OF CARE FOR ELDERLY HF PATIENTS WHO ADD EMPAGLIFLOZIN TO TREATMENT REGIMEN
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND DIRECT MEDICAL COSTS OF CHRONIC URTICARIA IN CHINA: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING PRIORITIES IN ETHNICALLY DIVERSE CAREGIVERS FOR PEOPLE WITH AGITATION IN ALZHEIMER'S DEMENTIA
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF AN INDIVIDUAL-LEVEL SIMULATION MODEL TO ASSESS THE COST CONSEQUENCES OF CARDIOVASCULAR-RENAL-METABOLIC SCREENING POLICIES FROM A NATIONAL PAYER AND SOCIETAL PERSPECTIVE
Mar 18, 2026, 21:38 PM -
THE IMPACT OF GENERALIZED RISK ADJUSTED COST-EFFECTIVENESS ANALYSIS (GRACE) ON VALUE ASSESSMENT: FROM FORMAL ADOPTION TO GLOBAL METHODOLOGICAL TRENDS
Mar 18, 2026, 21:38 PM -
MPACT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS TO TREAT OBESITY ON NON-GLP-1 COSTS AMONG COMMERCIALLY INSURED MEMBERS WITHOUT DIABETES: A THREE-YEAR RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
HEREDITARY ANGIOEDEMA IN MEXICO: ESTIMATING THE ECONOMIC BURDEN AND RESOURCE UTILIZATION IN PUBLIC HEALTHCARE
Mar 18, 2026, 21:38 PM -
A METHOD FOR CALCULATING THE TOTAL QALY OUTPUT AND THE MEAN COST/QALY ATTRIBUTABLE TO THE HEALTH SECTOR; THE CASE OF THE UK
Mar 18, 2026, 21:38 PM -
IMPACT OF EMERGENCY DEPARTMENT (ED) INVOLVEMENT AT CANCER DIAGNOSIS ON HEALTHCARE COSTS (HCC) ACROSS CANCER TYPES IN THE MEDICARE POPULATION
Mar 18, 2026, 21:38 PM -
EVALUATING THE DUAL-CHANNEL POLICY FOR INNOVATIVE ANTI-TUMOR DRUGS IN CHINA: EVIDENCE FROM POPULATION-LEVEL CLAIMS IN CITY A
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION WITH RECOMBINANT ADAMTS13 IN PATIENTS WITH CONGENITAL TTP: RESULTS FROM A PHASE 3 RANDOMIZED CLINICAL TRIAL
Mar 18, 2026, 21:38 PM -
AUTOMATED AMCP DOSSIER DEVELOPMENT USING A RETRIEVAL-AUGMENTED GENERATION (RAG)-BASED MULTI-AGENT APPROACH
Mar 18, 2026, 21:38 PM
